Does APIXABAN Cause Immune thrombocytopenia? 41 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 41 reports of Immune thrombocytopenia have been filed in association with APIXABAN (ELIQUIS). This represents 0.0% of all adverse event reports for APIXABAN.
41
Reports of Immune thrombocytopenia with APIXABAN
0.0%
of all APIXABAN reports
0
Deaths
16
Hospitalizations
How Dangerous Is Immune thrombocytopenia From APIXABAN?
Of the 41 reports, 16 (39.0%) required hospitalization, and 3 (7.3%) were considered life-threatening.
Is Immune thrombocytopenia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for APIXABAN. However, 41 reports have been filed with the FAERS database.
What Other Side Effects Does APIXABAN Cause?
Death (18,501)
Cerebrovascular accident (7,237)
Atrial fibrillation (5,690)
Off label use (5,590)
Thrombosis (5,298)
Fall (5,063)
Cardiac disorder (4,917)
Haemorrhage (4,770)
Dyspnoea (4,379)
Gastrointestinal haemorrhage (4,030)
What Other Drugs Cause Immune thrombocytopenia?
RITUXIMAB (335)
ALEMTUZUMAB (299)
PEMBROLIZUMAB (205)
DEXAMETHASONE (202)
ELTROMBOPAG OLAMINE (161)
NIVOLUMAB (151)
ROMIPLOSTIM (145)
OXALIPLATIN (141)
METHOTREXATE (132)
PREDNISONE (127)
Which APIXABAN Alternatives Have Lower Immune thrombocytopenia Risk?
APIXABAN vs APOMORPHINE
APIXABAN vs APRACLONIDINE
APIXABAN vs APREMILAST
APIXABAN vs APREPITANT
APIXABAN vs APROTININ